NASDAQ · NVNO
enVVeno Medical Corporation
$7.02+$0.28 (+4.08%)
enVVeno Medical Corporation’s quoted price sits in the lower half of its reported 52-week range, 73.37% below the high.
Loading market information…
OTC · EVARF · USD
Stock price, earnings
Quote as of Oct 6, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Lombard Medical, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Lombard Medical, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Lombard Medical, Inc. is a medical technology firm specializing in the creation, production, and distribution of endovascular stent-grafts designed for the repair of aortic aneurysms. The company serves a global market, with operations in the United States, United Kingdom, Germany, Japan, and other international regions. Its leading offering, Aorfix, is an endovascular stent-graft specifically engineered to address abdominal aortic aneurysms (AAAs) where the aneurysm's neck exhibits significant angulation, up to 90 degrees. Other solutions include the Altura endovascular stent graft system, tailored for more conventional AAA anatomies. Furthermore, Lombard Medical provides sophisticated delivery mechanisms: the Aorflex system ensures precise deployment of Aorfix within the abdominal aorta, while the IntelliFlex LP system further enhances the accuracy and control during Aorfix placement and deployment. The firm distributes its products through both its proprietary sales force and a network of distributors, primarily targeting state- or government-operated hospitals. Established in 2000, Lombard Medical, Inc. maintains its corporate headquarters in Didcot, United Kingdom.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$7.02+$0.28 (+4.08%)
enVVeno Medical Corporation’s quoted price sits in the lower half of its reported 52-week range, 73.37% below the high.
$0.00$0.00 (0.0%)
VMS Rehab Systems, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.02$0.00 (0.0%)
Easy Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Golden Developing Solutions, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
ScripsAmerica, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Todos Medical Ltd.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
That Marketing Solution, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Regnum Corp.: Communication Services · Entertainment.
